📊 DBD Key Takeaways
Investment Thesis
Diebold Nixdorf demonstrates solid operational fundamentals with strong free cash flow generation ($288.5M) and reasonable leverage metrics, but faces headwinds from modest revenue growth (+1.5% YoY) and declining net income (-3.0% YoY) despite operational improvements. The company's ability to convert operating cash flow into returns appears constrained by low profitability margins (2.5% net margin) and moderate returns on equity (8.6%), suggesting limited growth momentum in its legacy ATM and banking solutions market.
DBD Strengths
- Strong free cash flow generation at $288.5M with healthy 7.6% FCF margin, enabling debt reduction and shareholder returns
- Solid balance sheet with manageable debt-to-equity ratio of 0.85x and adequate interest coverage of 3.2x, indicating financial stability
- Operating cash flow of $300.7M significantly exceeds net income, suggesting quality earnings and capital-efficient operations
DBD Risks
- Anemic revenue growth of 1.5% YoY signals weak market demand and potential headwinds in legacy ATM/banking hardware segment
- Declining net income (-3.0% YoY) despite revenue growth indicates margin compression and operational challenges, offset only by one-time EPS gains
- Low profitability margins (2.5% net, 6.4% operating) and weak returns on equity (8.6%) suggest limited competitive advantages and pricing power in maturing markets
Key Metrics to Watch
- Operating margin trend and gross margin sustainability amid inflationary pressures
- Year-over-year revenue growth acceleration, particularly in software and services segments
- Free cash flow conversion rate and debt reduction trajectory toward optimal capital structure
DBD Financial Metrics
💡 AI Analyst Insight
DIEBOLD NIXDORF, Inc presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
DBD Profitability Ratios
DBD vs Technology Sector
How DIEBOLD NIXDORF, Inc compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
DBD Balance Sheet & Liquidity
DBD 5-Year Financial Trend
5-Year Trend Summary: DIEBOLD NIXDORF, Inc's revenue has declined by 14% over the 5-year period, indicating business contraction. The most recent EPS of $16.74 reflects profitable operations.
DBD Growth Metrics (YoY)
DBD Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $927.1M | -$22.1M | $-0.59 |
| Q2 2025 | $915.2M | $300.0K | $0.01 |
| Q1 2025 | $841.1M | -$8.3M | $-0.22 |
| Q3 2024 | $351.6M | -$8.9M | $-0.24 |
| Q2 2024 | $922.2M | $300.0K | $0.01 |
| Q1 2024 | $858.1M | -$14.6M | $-0.39 |
| Q3 2023 | $351.6M | -$26.5M | $-0.63 |
| Q2 2023 | $851.7M | -$199.2M | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
DBD Capital Allocation
DBD SEC Filings
Access official SEC EDGAR filings for DIEBOLD NIXDORF, Inc (CIK: 0000028823)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| Mar 17, 2026 | 4 | xslF345X05/wk-form4_1773784205.xml | View → |
| Mar 9, 2026 | 4 | xslF345X05/wk-form4_1773094854.xml | View → |
| Mar 9, 2026 | 4 | xslF345X05/wk-form4_1773094848.xml | View → |
| Mar 3, 2026 | 4 | xslF345X05/wk-form4_1772579208.xml | View → |
| Mar 3, 2026 | 4 | xslF345X05/wk-form4_1772579203.xml | View → |
❓ Frequently Asked Questions about DBD
What is the AI rating for DBD?
DIEBOLD NIXDORF, Inc (DBD) has an AI rating of HOLD with 62% confidence, based on fundamental analysis of SEC EDGAR filings.
What are DBD's key strengths?
Strong free cash flow generation at $288.5M with healthy 7.6% FCF margin, enabling debt reduction and shareholder returns. Solid balance sheet with manageable debt-to-equity ratio of 0.85x and adequate interest coverage of 3.2x, indicating financial stability.
What are the risks of investing in DBD?
Anemic revenue growth of 1.5% YoY signals weak market demand and potential headwinds in legacy ATM/banking hardware segment. Declining net income (-3.0% YoY) despite revenue growth indicates margin compression and operational challenges, offset only by one-time EPS gains.
What is DBD's revenue and growth?
DIEBOLD NIXDORF, Inc reported revenue of $3.8B.
Does DBD pay dividends?
DIEBOLD NIXDORF, Inc does not currently pay dividends.
Where can I find DBD SEC filings?
Official SEC filings for DIEBOLD NIXDORF, Inc (CIK: 0000028823) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DBD's EPS?
DIEBOLD NIXDORF, Inc has a diluted EPS of $2.54.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.